PROM1 and colorectal carcinoma: cEtOH from CLU and COK were also able to decrease the expression of genes associated with the CRC CSC phenotype such as CD24, CD133, NANOG and OCT-4, which have been associated with drug resistance, recurrence and metastasis [58,59].